This CME-accredited, case-based activity is designed to enhance clinical decision-making through the application of current evidence and best practices in GU oncology. Learners will engage with interactive scenarios that emphasize personalized treatment approaches, safe use of emerging therapies, and effective management of treatment-related toxicities.
Course Accreditations
Course Summary
| Events Starts | Events Ends |
|---|---|
| 1/1/2025 | 12/31/2025 |
- Medical oncologists
- Radiation oncologists
- Surgical oncologists
- Oncology residents/fellows
- Oncology NPs/PAs
- Oncology pharmacists
- Oncology nurses
Target Audience
- Evaluate current evidence to inform treatment decisions in patients with advanced genitourinary cancers.
- Integrate biomarker testing into clinical practice to guide personalized therapy.
- Recognize and manage adverse effects associated with novel targeted therapies.
Learning Objectives
Upon successful completion of this educational activity, participants will be able to: